Biovie Inc Stock Revenue
| BIVI Stock | USD 1.67 0.02 1.21% |
Biovie Inc fundamentals help investors to digest information that contributes to Biovie's financial success or failures. It also enables traders to predict the movement of Biovie Stock. The fundamental analysis module provides a way to measure Biovie's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biovie stock.
| Last Reported | Projected for Next Year |
Biovie | Revenue |
Biovie Inc Company Revenue Analysis
Biovie's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Historical and Projected quarterly revenue of Biovie
Projected quarterly revenue analysis of Biovie Inc provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of Biovie match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in Biovie's stock price.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Biovie Current Deferred Revenue
Current Deferred Revenue |
|
Based on the latest financial disclosure, Biovie Inc reported 0.0 of revenue. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The revenue for all United States stocks is 100.0% higher than that of the company.
Biovie Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biovie's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biovie could also be used in its relative valuation, which is a method of valuing Biovie by comparing valuation metrics of similar companies.Biovie is currently under evaluation in revenue category among its peers.
Biovie Institutional Holders
Institutional Holdings refers to the ownership stake in Biovie that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Biovie's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Biovie's value.| Shares | Newbridge Financial Services Group, Inc. | 2024-12-31 | 1.4 K | New Wave Wealth Advisors Llc | 2024-12-31 | 800 | Advisor Group Holdings, Inc. | 2024-09-30 | 602 | Wells Fargo & Co | 2024-09-30 | 550 | Spire Wealth Management | 2024-12-31 | 250 | Jpmorgan Chase & Co | 2024-09-30 | 154 | Bank Of America Corp | 2024-09-30 | 112 | Steward Partners Investment Advisory, Llc | 2024-09-30 | 100.0 | Goss Wealth Management Llc | 2024-09-30 | 100.0 | Drive Wealth Management, Llc | 2024-12-31 | 60 K | Vanguard Group Inc | 2024-09-30 | 56.8 K |
Biovie Fundamentals
| Return On Equity | -2.08 | ||||
| Return On Asset | -0.67 | ||||
| Current Valuation | 13.01 M | ||||
| Shares Outstanding | 17.77 M | ||||
| Shares Owned By Insiders | 13.69 % | ||||
| Shares Owned By Institutions | 9.98 % | ||||
| Number Of Shares Shorted | 1.7 M | ||||
| Price To Earning | 18.12 X | ||||
| Price To Book | 2.08 X | ||||
| EBITDA | (31.95 M) | ||||
| Net Income | (32.12 M) | ||||
| Cash And Equivalents | 18.64 M | ||||
| Cash Per Share | 0.62 X | ||||
| Total Debt | 6.11 M | ||||
| Debt To Equity | 3.34 % | ||||
| Current Ratio | 4.50 X | ||||
| Book Value Per Share | 2.50 X | ||||
| Cash Flow From Operations | (27.95 M) | ||||
| Short Ratio | 0.15 X | ||||
| Earnings Per Share | (5.08) X | ||||
| Target Price | 5.0 | ||||
| Number Of Employees | 14 | ||||
| Beta | 0.9 | ||||
| Market Capitalization | 29.32 M | ||||
| Total Asset | 25.21 M | ||||
| Retained Earnings | (334.23 M) | ||||
| Working Capital | 14.7 M | ||||
| Current Asset | 9 K | ||||
| Current Liabilities | 961 K | ||||
| Net Asset | 25.21 M |
About Biovie Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biovie Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biovie using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biovie Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| EBR | Centrais Electricas Brasileiras | |
| HE | Hawaiian Electric Industries | |
| VFC | VF Corporation | |
| BVHMF | Vistry Group PLC | |
| S | SentinelOne |
Check out Biovie Piotroski F Score and Biovie Altman Z Score analysis. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biovie. If investors know Biovie will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biovie listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Biovie Inc is measured differently than its book value, which is the value of Biovie that is recorded on the company's balance sheet. Investors also form their own opinion of Biovie's value that differs from its market value or its book value, called intrinsic value, which is Biovie's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biovie's market value can be influenced by many factors that don't directly affect Biovie's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biovie's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biovie is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biovie's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.